Human antibody reveals hidden vulnerability in influenza virus

The ever-changing “head” of an influenza virus protein has an unexpected Achilles heel, report scientists.

A colorized, transmission electron micrograph showing a swine influenza virus particles (blue) attached to and budding off a cell (orange). Photo: NIAID

The team discovered and characterized the structure of a naturally occurring human antibody that recognizes and disrupts a portion of the hemagglutinin (HA) protein that the virus uses to enter and infect cells. The investigators determined that the antibody, FluA-20, binds tightly to an area on the globular head of the HA protein that is only very briefly accessible to antibody attack. The site was not expected to be vulnerable to such a strike.

James E. Crowe, Jr., M.D., of Vanderbilt University Medical Center, Nashville, Tennessee, and Ian A. Wilson, D. Phil., of The Scripps Research Institute, San Diego, California, led the team. They isolated FluA-20 antibody from a person who had received many influenza immunizations.

In a series of experiments, they showed that FluA-20 can “reach into” an otherwise inaccessible part of the three-part HA trimer molecule and cause it to fall apart, thus preventing the spread of virus from cell to cell.

This discovery came as a surprise because this region of trimeric HA was thought to be stable and inaccessible to antibodies.

Moreover, this region — unlike the rest of HA’s head — varies little from strain to strain. In theory, antibody-based therapeutics directed at that precise region would be effective against many strains of influenza A virus. Similarly, vaccines designed to elicit antibodies against this target might provide long-lasting protection against any influenza strain, potentially eliminating the need for annual seasonal influenza vaccination.

In mouse studies, FluA-20 prevented infection or illness when the animals were exposed to four different influenza A viral subtypes that cause disease in humans. Two viruses used in the experiments, H1N1 and H5N1, are Group 1 influenza subtypes, while the two others, H3N2 and H7N9, are members of Group 2. (National Institutes of Health)

YOU MAY ALSO LIKE

Study finds gut microbiome can control antitumor immune function in liver

Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver.

Method for Early Detection of Pancreatic Cancer

Researchers developed a noninvasive method to detect both early- and late-stage pancreatic cancer. If the findings are confirmed in a larger group, they could lead to routine tests that catch pancreatic tumors early and boost survival rates.

Predicting Alzheimer's Disease May Be Possible Using Eye Exam

Researchers have detected evidence suggesting Alzheimer's in older patients who had no symptoms of the disease by using technology similar to what is found in many eye doctors' offices.

Atlas of Human Malformation Syndromes in Diverse Populations

Researchers with the National Human Genome Research Institute have collaborated with physicians and medical geneticists around the world to create the Atlas of Human Malformation Syndromes in Diverse Populations.

Vitamin D Levels Predict Multiple Sclerosis Progression

Among people with early-stage multiple sclerosis (MS), those with higher blood levels of vitamin D had better outcomes during 5 years of follow-up. Identifying and correcting vitamin D insufficiency could aid in the early treatment of MS.

Rare cancers may masquerade as ADHD in children

Rare tumors called pheochromocytomas and paragangliomas may cause the same symptoms as attention deficit hyperactivity disorder (ADHD) in children, leading to inappropriate treatment that could worsen their symptoms and potentially endanger their health.